Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | KDM3B | Q7LBC6 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 5-Bromouracil SCHEMBL5145285 | 0.94 | ALDH1A1 (0.40) | KMT2ATDP1KDM3BALDH1A1LMNA | |
| SCHEMBL104627 | 0.87 | KMT2A (0.48) | KMT2ATDP1KDM3BALDH1A1MEN1 | |
| SCHEMBL101944 | 0.84 | LMNA (0.41) | LMNASMN1; SMN2 | |
| SCHEMBL9109566 | 0.74 | KMT2A (0.46) | KMT2ATDP1KDM3BALDH1A1MEN1 | |
| SCHEMBL7206108 | 0.73 | CYP3A4 (0.33) | LMNASMN1; SMN2 | |
| SCHEMBL28991875 | 0.71 | GAA (0.46) | LMNA | |
| SCHEMBL18653592 | 0.71 | KMT2A (0.37) | KMT2ATDP1KDM3B | |
| SCHEMBL31258192 | 0.71 | LMNA (0.33) | LMNASMN1; SMN2 | |
| SCHEMBL11739894 | 0.71 | — | — | |
| SCHEMBL4371043 | 0.71 | CRBN (0.40) | LMNASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3484521-B1 | POLY(L-LYSINE ISOPHTHALAMIDE) (PLP) POLYMERS WITH HYDROPHOBIC PENDANT CHAINS | ALPHACELLS BIOTECHNOLOGIES LTD (GB) | 2021-04-07 | — | — | EP | disclosed |
| EP-3430143-B1 | INHIBITORS OF SRSF1 TO TREAT NEURODEGENERATIVE DISORDERS | UNIV SHEFFIELD (GB) | 2021-03-03 | — | — | EP | disclosed |
| EP-3484521-A1 | POLY(L-LYSINE ISOPHTHALAMIDE) (PLP) POLYMERS WITH HYDROPHOBIC PENDANT CHAINS | Imperial Innovations PLC (GB) | 2019-05-22 | — | — | EP | disclosed |
| EP-3430143-A1 | INHIBITORS OF SRSF1 TO TREAT NEURODEGENERATIVE DISORDERS | University of Sheffield (GB) | 2019-01-23 | — | — | EP | disclosed |
| WO-2018011580-A1 | POLY(L-LYSINE ISOPHTHALAMIDE) (PLP) POLYMERS WITH HYDROPHOBIC PENDANT CHAINS | IMPERIAL INNOVATIONS PLC (GB) | 2018-01-18 | — | — | WO | disclosed |
| WO-2017207979-A1 | INHIBITORS OF SRSF1 TO TREAT NEURODEGENERATIVE DISORDERS | UNIVERSITY OF SHEFFIELD (GB) | 2017-12-07 | — | — | WO | disclosed |
| EP-3207137-A1 | PHARMACEUTICAL COMPOSITION FOR TREATING A VIRAL INFECTION | London School Of Hygiene & Tropical Medicine (GB) | 2017-08-23 | — | — | EP | disclosed |
| EP-3041480-A1 | ANTI-VIRAL THERAPY | The University of York (GB) | 2016-07-13 | — | — | EP | disclosed |
| WO-2016059376-A1 | PHARMACEUTICAL COMPOSITION FOR TREATING A VIRAL INFECTION | LONDON SCHOOL OF HYGIENE & TROPICAL MEDICINE (GB) | 2016-04-21 | — | — | WO | disclosed |
| WO-2015036737-A1 | BIOMARKERS FOR DISEASE STRATIFICATION | UNIVERSITY OF SHEFFIELD (GB) | 2015-03-19 | — | — | WO | disclosed |
| WO-2011110838-A2 | DIFFERENTIATION FACTOR | PROCURE THERAPEUTICS LIMITED (GB) | 2011-09-15 | — | — | WO | disclosed |
| WO-2011058300-A2 | INDUCED PLURIPOTENT STEM CELL | THE UNIVERSITY OF NOTTINGHAM (GB) | 2011-05-19 | — | — | WO | disclosed |
| WO-2011036450-A2 | SPLICE VARIANTS | THE UNIVERSITY OF YORK (GB) | 2011-03-31 | — | — | WO | disclosed |
| WO-2010100437-A9 | PRODUCTION OF PROTEIN | UNIVERSITY OF SHEFFIELD (GB) | 2010-10-07 | — | — | WO | disclosed |
| WO-2010100437-A2 | PRODUCTION OF PROTEIN | UNIVERSITY OF SHEFFIELD (GB) | 2010-09-10 | — | — | WO | disclosed |
| EP-2219654-A2 | TREATMENT OF INFLAMMATORY DISEASES | Medical Research Council (GB) | 2010-08-25 | — | — | EP | disclosed |
| WO-2010089559-A1 | CANCER DIAGNOSIS AND TREATMENT | CIZZLE BIOTECHNOLOGY LIMITED (GB) | 2010-08-12 | — | — | WO | disclosed |
| WO-2009053683-A2 | TREATMENT OF INFLAMMATORY DISEASES | MEDICAL RESEARCH COUNCIL (GB) | 2009-04-30 | — | — | WO | disclosed |
| EP-1891216-A2 | HYBRID INTERFERING RNA | THE UNIVERSITY OF YORK (GB) | 2008-02-27 | — | — | EP | disclosed |
| WO-2006125977-A2 | HYBRID INTERFERING RNA | THE UNIVERSITY OF YORK (GB) | 2006-11-30 | — | — | WO | disclosed |